Oak Street Health, Inc. (NYSE:OSH) COO Geoffrey M. Price sold 12,112 shares of the firm’s stock in a transaction dated Monday, May 3rd. The shares were sold at an average price of $63.27, for a total value of $766,326.24. Following the completion of the sale, the chief operating officer now owns 3,817,437 shares of the company’s stock, valued at $241,529,238.99. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.
Oak Street Health stock opened at $61.07 on Tuesday. Oak Street Health, Inc. has a 52 week low of $37.11 and a 52 week high of $66.31. The company’s 50 day moving average price is $58.43 and its two-hundred day moving average price is $55.38.
Oak Street Health (NYSE:OSH) last posted its quarterly earnings results on Monday, March 8th. The company reported ($0.40) EPS for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.15). The company had revenue of $248.70 million for the quarter, compared to the consensus estimate of $231.79 million. The company’s revenue was up 43.3% on a year-over-year basis. As a group, sell-side analysts expect that Oak Street Health, Inc. will post -0.63 earnings per share for the current fiscal year.
OSH has been the subject of several research reports. Wolfe Research initiated coverage on Oak Street Health in a research note on Thursday, January 28th. They issued an “outperform” rating and a $62.00 target price for the company. Piper Sandler lifted their price target on Oak Street Health from $59.00 to $69.00 in a research note on Wednesday, February 17th. Canaccord Genuity began coverage on Oak Street Health in a research note on Tuesday, March 2nd. They set a “buy” rating and a $67.00 price target for the company. Cantor Fitzgerald began coverage on Oak Street Health in a research note on Monday, April 26th. They set an “overweight” rating and a $75.00 price target for the company. Finally, Zacks Investment Research downgraded Oak Street Health from a “hold” rating to a “sell” rating in a research note on Saturday, February 20th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and thirteen have assigned a buy rating to the stock. Oak Street Health has a consensus rating of “Buy” and an average target price of $67.54.
About Oak Street Health
Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2020, it operated 79 centers in Illinois, Indiana, Michigan, Mississippi, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, Tennessee, and Texas.
Read More: What is a short straddle?
Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.